TFRC and breast cancer: CD71, a transferrin receptor, is an important mediator of ferroptosis, and its degradation, mediated by NEDD4L via the ubiquitin–proteasome system, inhibits ferroptosis in breast cancer cells after exposure to ionizing radiation (Candelaria et al., 2021; Liu et al., 2022).